CCL18 and breast cancer: These TAMs, in turn, produce elevated levels of CCL18, which induces EMT in breast cancer cells via the phosphatidylinositol 3-kinase (PI3K)/Akt/glycogen synthase kinase 3β (GSK3β)/SNAIL signaling pathway.